within Pharmacolibrary.Drugs.ATC.A;

model A16AA06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.00022666666666666666,
    adminDuration  = 600,
    adminMass      = 3000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A16AA06</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Betaine (trimethylglycine) is an osmolyte and methyl donor used primarily for the treatment of homocystinuria, an inherited condition characterized by high levels of homocysteine. It is approved as adjunctive therapy to lower plasma homocysteine levels in patients with homocystinuria due to cystathionine beta-synthase, 5,10-methylenetetrahydrofolate reductase, or cobalamin defects. Betaine is generally administered orally as a prescription medication.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported in pediatric and adult patients with homocystinuria, after oral administration of betaine anhydrous.</p><h4>References</h4><ol><li><p>Schwahn, BC, et al., &amp; Wendel, U (2003). Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria. <i>British journal of clinical pharmacology</i> 55(1) 6–13. DOI:<a href=\"https://doi.org/10.1046/j.1365-2125.2003.01717.x\">10.1046/j.1365-2125.2003.01717.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12534635/\">https://pubmed.ncbi.nlm.nih.gov/12534635</a></p></li><li><p>Imbard, A, et al., &amp; Schiff, M (2022). Efficacy and pharmacokinetics of betaine in CBS and cblC deficiencies: a cross-over randomized controlled trial. <i>Orphanet journal of rare diseases</i> 17(1) 417–None. DOI:<a href=\"https://doi.org/10.1186/s13023-022-02567-4\">10.1186/s13023-022-02567-4</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36376887/\">https://pubmed.ncbi.nlm.nih.gov/36376887</a></p></li><li><p>Simpson, M, &amp; Parrott, EL (1980). Oral and rectal absorption of chloral hydrate and its betaine complex. <i>Journal of pharmaceutical sciences</i> 69(2) 227–228. DOI:<a href=\"https://doi.org/10.1002/jps.2600690235\">10.1002/jps.2600690235</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7359335/\">https://pubmed.ncbi.nlm.nih.gov/7359335</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A16AA06;
